1) Malignant ascites formation
恶性腹水形成
2) malignant ascites
恶性腹水
1.
A study on therapy combined TNP-470 with highly agglutinative staphylococcin for malignant ascites in mice;
0-氯乙酰-氨甲酰基烟曲霉醇联合高聚生治疗恶性腹水的实验性研究
2.
Effect of Aloe on rat models of malignant ascites;
芦荟对小鼠恶性腹水模型的影响
3.
An Evaluation of sCD44v6 and Type Ⅳ Collagenase in Malignant Ascites;
可溶性CD44v6和Ⅳ型胶原酶在恶性腹水中的诊断价值
3) malignant hydrothorax or hydroperitoneum
恶性胸腹水
1.
Clinical study on malignant hydrothorax or hydroperitoneum treated with intracavitary perfusion chemotherapy combined with local endogenetic thermotherapy
胸腹腔灌注化疗联合内生场热疗治疗恶性胸腹水
4) refractory malignant ascites
难治性恶性腹水
1.
A clinical trail of Vp-16 intraperitoneal chemotherapy in the treatment of refractory malignant ascites;
足叶乙甙腹腔灌注治疗难治性恶性腹水临床观察
5) gynecological malignant ascites
妇科恶性腹水
1.
Objective To observe the closer clinical curative effects of controlling gynecological malignant ascites by EP chemotherapy combined with Carboplatin intraperitoneal chemotherapy after duct deposited.
目的观察置管引流后卡铂灌注化疗联合EP方案治疗妇科恶性腹水的临床近期疗效。
6) malignant peritoneal effusion/drug therapy
恶性腹水/药物疗法
补充资料：肝硬化腹水形成
肝硬化腹水形成
肝硬化失代偿期常见体征之一，是由门静脉高压和肝功能不全等原因所造成。在多数病人腹水聚积较慢，需数月时间。腹水增多时，表现为腹部膨隆，腹壁皮肤紧张发亮，皮下静脉清晰、常因膈肌抬高而出现呼吸困难和心悸等症状。腹水检查为淡黄色*漏出液。治疗可控制钠、水摄人；应用利尿剂，补充蛋白质，必要时手术治疗。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条